Deborah M. Messemer - 10 Jun 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 17:46:56 UTC
Previous filing
27 May 2021
Next filing
13 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +28,015 $0.000000 28,015 10 Jun 2021 Common Stock 28,015 $25.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 12 equal monthly installments beginning July 10, 2021.